Neurocrine Access Support for CRENESSITY is a free, comprehensive program designed to ensure your patients receive the support and guidance they need to start and continue on their medication. Our goal is to reduce administrative burden for your practice while helping patients start and stay on therapy without unnecessary delays.
Neurocrine Access Support is available for patients prescribed CRENESSITY. CRENESSITY is indicated as adjunctive treatment to glucocorticoid replacement to control androgens in adults and pediatric patients 4 years of age and older with classic congenital adrenal hyperplasia (CAH).